Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stivant vs Avastin in Metastatic Colorectal Cancer
NCT03288987Phase 3Completed
- Sponsor
- AryoGen Biopharma
- Start
- Oct 2016
- Primary completion
- Jul 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of Stivant in metastatic colorectal cancer (mCRC), sponsored by AryoGen Biopharma. Started Oct 2016; status: completed.
02
Drugs
Stivant
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03288987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03288987.